Project Details
| Short title | Phase 1 Dose Escalation Study of Clofarabine and Liposomal Daunorubicin and Childhood and Adolescent AML - CLOUD Study |
|---|---|
| Status | Finished |
| Effective start/end date | 1/11/08 → 31/12/18 |
Funding
- GENZYME EUROPE
- BLOODWISE
Phase 1 Dose Escalation Study of Clofarabine and Liposomal Daunorubicin and Childhood and Adolescent AML - CLOUD Study
- Kearns, Pamela (Principal Investigator)